Related Experiment Video
Updated: May 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care
Walid F Gellad1,2,3, Yi-Fan Chen4, Tae Woo Park2,5
1Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
This study integrates machine learning (ML) for opioid overdose risk prediction with electronic health record (EHR) nudges to improve prescribing behaviors and reduce overdose deaths. The mPROVEN trial tests a scalable intervention in primary care settings.
Area of Science:
- Public Health
- Health Informatics
- Clinical Trials
Background:
- Opioid overdose is a leading preventable cause of death in the US.
- Current risk assessment methods are imprecise, leading to misclassification of patient risk.
- Machine learning (ML) and electronic health record (EHR) interventions can improve overdose risk prediction and reduction.
Purpose of the Study:
- To evaluate the Machine Learning Prediction and Reducing Overdoses With EHR Nudges (mPROVEN) clinical trial.
- To test if integrating an ML overdose risk model with EHR nudges improves prescribing behaviors and reduces overdose risk.
- To assess the impact on evidence-based prescribing and patient overdose outcomes.
Main Methods:
- Pragmatic cluster randomized controlled trial in primary care practices.
- Adult patients identified with elevated overdose risk by ML algorithm.
- Three arms: usual care, EHR risk flag only, EHR risk flag + nudges (active choice, accountable justification alerts).
- Primary outcome: composite measure of safer opioid prescribing at 4 months.
- Intention-to-treat analysis using linear mixed-effects models.
Main Results:
- Enrollment for the primary analysis cohort (n=798) completed in May 2025.
- Enrollment for secondary analyses completed in December 2025 (n=1662).
- Primary cohort analyses began in January 2026, with results expected by mid-2027.
Conclusions:
- The mPROVEN study is a pioneering pragmatic randomized controlled trial.
- It integrates ML-based opioid overdose risk prediction with behavioral nudges in a large EHR system.
- The study aims to reduce opioid overdose risk through a scalable, low-touch intervention in primary care.
Related Concept Videos
Drug Dosing: Obese Patients
Dosage Regimens: Designs and Approaches
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dosage Regimen Designs: Nomograms and Tabulations
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
